The Higher Education Commission (HEC) has opened applications for fully funded PhD scholarships under the US-Pakistan Knowledge Corridor Project, offering Pakistani students a chance to study at ...

After dropping headline-grabbing phase 3 data for its pancreatic cancer candidate daraxonrasib last week, Revolution Medicines is not resting on its laurels. The Bay Area biotech has spent several ...

Islamabad: The Higher Education Commission (HEC) is preparing to introduce a blockchain-powered digital degree attestation system that will allow students to verify their academic credentials online ...

A Revolution Medicines drug helped pancreatic cancer patients live nearly six months longer compared to those treated with standard of care chemotherapy, meeting the goals of a pivotal study in this ...

Revolution Medicines’ pan-RAS inhibitor helped patients with a highly aggressive form of pancreatic cancer live an average of six months longer than chemotherapy, hitting a goal of the phase 3 study.